About Cadex Genomics

Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into the therapy response. By combining proven approaches to measuring DNA with cutting-edge technology to improve accuracy and sensitivity Cadex Genomics provides unique insight into therapy response using simple blood draws.

Alibrex is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The test is optimized to maximize NPV, that is, minimize the number of false non-responders.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
4340 Duncan Avenue, Suite 256, St. Louis, MO 63011, US
description icon
Founded
2018
description icon
Keywords
Biotechnology, Oncology, Molecular Diagnostics, Genomics

Frequently Asked Questions about Cadex Genomics

Who is the CEO of Cadex Genomics?

Bill Haack is the CEO of Cadex Genomics. To contact Bill Haack email at [email protected] or [email protected]. Or you may call 3202961801

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more